Effect of licorice flavonoid oil on visceral fat in obese subjects in the United States
- 126 Downloads
Abdominal obesity, or accumulation of visceral fat, is mainly associated with the onset of metabolic syndrome. Licorice flavonoid oil (LFO) consisting of licorice hydrophobic polyphenols in mediumchain triglycerides (MCT) is a new functional food ingredient effective in preventing metabolic syndrome. We have demonstrated significant effects of LFO on reduction of total body fat and visceral fat together with body weight in overweight Japanese subjects. Obesity is a more serious problem in Western countries such as Europe and the United States compared to Japan. We hypothesized that LFO could also work for abdominally obese people in Western countries. We therefore tested the effects of 300 mg LFO concentrate solution taken once daily with evening meals for up to 12 weeks in obese adult male and female subjects in the United States. Results showed that visceral fat, as measured by an abdominal CT scan, waist circumference measurements and waist-to-hip ratio significantly decreased in subjects in the LFO group compared to the placebo group at Week 12. The side-effect profile of LFO was indistinguishable from placebo. Moreover, no adverse trends or toxicologically meaningful differences in haematology and chemistry test results, vital signs or physical examinations were observed that were attributable to LFO. These results indicate that LFO is a safe food ingredient for preventing metabolic syndrome not only in Japan but also in Western countries such as Europe and the United States.
Keywordslicorice flavonoid Glycyrrhiza glabra L. metabolic syndrome visceral fat, total body fat abdominal fat
licorice flavonoid oil
body mass index
basal metabolic rate
Unable to display preview. Download preview PDF.
- 9.Aoki F, Honda S, Kishida H, Kitano M, Arai N, Tanaka H, Yokota S, Nakagawa K, Asakura T, Nakai Y, Mae T (2007) Suppression by licorice flavonoids of abdominal fat accumulation and body weight gain in high-fat diet-induced obese C57BL/6J mice. Biosci Biotechnol Biochem 71:206–214CrossRefGoogle Scholar
- 16.Harris JA, Benedict FG (1919) A biometric study of basal metabolism in man. Carnegie Institution of Washington, WashingtonGoogle Scholar
- 17.U.S. Department of Health and Human Services, PHS (1996) NHANES III Anthropometric Procedures Video. U.S. Government Printing Office Stock Number 017-022-01335-5. U.S. GPO, Public Health Service, Washington, D.C.Google Scholar
- 18.World Health Organization Media centre (2013) Obesity and overweight. Fact sheet no. 311, updated March 2013. http://who.int/mediacentre/factsheets/fs311/en/index.html Google Scholar
- 22.Fujioka S, Matsuzawa Y, Tokunaga K, Keno Y, Kobatake T, Tarui S (1991) Treatment of visceral fat obesity. Int J Obes 15:59–65Google Scholar
- 23.Shimomura I, Tokunaga K, Kotani K, Keno Y, Yanase-Fujiwara M, Kanosue K, Jiao S, Funahashi T, Kobatake T, Yamamoto T, Matsuzawa Y (1993) Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise. Am J Physiol 265:E44–50Google Scholar